(Q42553965)

2 November 2017

Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes (English)

1 reference

2 November 2017

1 reference

Olivia R Blume

1

1 reference

PMCID

3321556

2 November 2017

Sarah E Yost

series ordinal

2

1 reference

PMCID

3321556

2 November 2017

Bruce Kaplan

series ordinal

3

1 reference

2 November 2017

24 March 2012

1 reference

Journal of transplantation

2 November 2017

1 reference

2 November 2017

2012

1 reference

2 November 2017

201754

1 reference

Creative Commons Attribution 3.0 Unported

2 November 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Antibody-mediated rejection in kidney transplantation: an update

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Rejection of the kidney allograft

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Abrogation of anti-HLA antibodies via proteasome inhibition

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Monitoring and treating posttransplant human leukocyte antigen antibodies

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Banff 07 classification of renal allograft pathology: updates and future directions

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Transplant: immunology and treatment of rejection

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Complement C4d in graft capillaries -- the missing link in the recognition of humoral alloreactivity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

The HLA system. First of two parts

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Histopathology and immunophenotype of the spleen during acute antibody-mediated rejection.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Impact of rituximab therapy for treatment of acute humoral rejection

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Experience with antibody-mediated rejection in kidney allograft recipients.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Rituximab as treatment for refractory kidney transplant rejection

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321556

Serum major-histocompatibility-complex class I-related chain A antibody detection for the evaluation of graft dysfunction in renal allograft recipients

16 August 2018

1 reference

12 December 2020

Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation

1 reference

12 December 2020

Protein A immunoadsorption therapy in the highly sensitized kidney transplant candidates

1 reference

12 December 2020

Pharmacodynamics of Rituximab in Kidney Transplantation

1 reference

12 December 2020

Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome

1 reference

12 December 2020

Rituximab therapy for acute humoral rejection after kidney transplantation

1 reference

12 December 2020

Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients

1 reference

12 December 2020

Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report

1 reference

12 December 2020

Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation

1 reference

12 December 2020

Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/201754

1 reference

2 November 2017

1 reference

2 November 2017

1 reference

PMCID

3321556